Since SPA17 expression was more frequently observed in samples from patients with lymph node metastasis of breast cancer and the triple negative and HER2 positive breast cancer specimens, we supposed that SPA17 expression might affect the prognosis of breast cancer patients. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.